Search Results - Schneider, Claus-Peter

Randomized phase II study of Erlotinib in combination with placebo or R1507, a monoclonal antibody to insulin-like growth factor-1 receptor, for advanced-stage non-small-cell lung... by Ramalingam, Suresh (Author) , Spigel, David R. (Author) , Chen, David (Author) , Steins, Martin (Author) , Engelman, Jeffrey A. (Author) , Schneider, Claus-Peter (Author) , Novello, Silvia (Author) , Eberhardt, Wilfried E. E. (Author) , Crino, Lucio (Author) , Habben, Kai (Author) , Liu, Lian (Author) , Jänne, Pasi A. (Author) , Brownstein, Carrie M. (Author) , Reck, Martin (Author) ,

• Verlag, lizenzpflichtig, Volltext
• Verlag, lizenzpflichtig, Volltext